Position in NVO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$238,837
New position
Shares Held
4,982
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#962
of 1,348 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Monte Financial Group, LLC holds $28,595,491 across 7 Drug Manufacturers - General names. NVO ranks #6 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
33,979 | $8,629,646 | |
| 2 | NVS |
Novartis AG
|
44,535 | $6,979,525 | |
| 3 | MRK |
Merck & Co., Inc.
|
51,508 | $6,618,778 | |
| 4 | PFE |
Pfizer Inc
|
173,412 | $4,175,760 | |
| 5 | AZN |
Astrazeneca PLC
|
9,226 | $1,749,434 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
4,982 | $238,837 | |
| 7 | AMGN |
Amgen Inc
|
562 | $203,511 |
All Filings in NVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,837 | 4,982 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||